Seraph Biosciences, Inc

Seraph Biosciences, Inc. is a biomedical device company headquartered in Detroit, Michigan and was founded in 2014. The company's mission is to commercialize its innovative diagnostic technology, Seraspec®, which represents a revolutionary approach to screening and identifying bacterial, viral, and fungal pathogens. The team comprises experienced academic physicians, biomedical engineers, artificial intelligence experts, and device commercialization professionals, all dedicated to addressing major public health crises. The groundbreaking Seraspec®, based on Raman Spectroscopy, eliminates the need for laborious and expensive laboratory-based specimen collection, processing, and pathogen identification, while simultaneously enhancing safety, efficiency, accuracy, and profitability. This portable, point-of-need technology enables real-time pathogen detection and identification, significantly advancing the fight against infections. In January 2020, the company secured a Venture Round investment from the Tech Startup Stabilization Fund. Seraph Biosciences, Inc. is set to play a pivotal role in shaping the future of pathogen detection and transforming the biopharma and biotechnology industries.